AbbVie Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ABBV34.SA | BMY | LLY | JNJ | PFE | AZN | |
|---|---|---|---|---|---|---|
| Market cap | 2.55T | 122.05B | 1.12T | 615.87B | 168.60B | 256.54B |
| P/E (TTM) | 77.8 | 13.2 | 42.2 | 38.8 | 38.9 | 23.8 |
| Forward P/E | — | 9.0 | 26.6 | 21.8 | 10.2 | 14.6 |
| Price/book | -5.3 | 5.5 | 33.1 | 7.2 | 2.0 | 5.1 |
| Dividend yield | 1.72% | 4.22% | 0.55% | 2.10% | 5.81% | 1.94% |
| 1-year change | +15.18% | +37.07% | +55.39% | +31.92% | +19.81% | −1.39% |
| Today | +0.79% | −1.35% | +0.43% | +0.90% | +0.48% | −0.76% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All ABBV34.SA news ›AbbVie’s Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
AbbVie's stock has surged nearly 29% this year, but a rising share price compresses the yield even as the dividend keeps growing. Before adding shares for income, consider what the pending Apogee deal and lingering debt load could mean…
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Not all high-yield dividend stocks are created equal. Some are genuine income compounders, while others are traps. And the current environment, with interest rates on the rise, makes it more difficult to differentiate the good from the…
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
AbbVie (ABBV +0.71%), which accounts for 6.2% of my portfolio, is one of my favorite long-term dividend stocks. The pharmaceutical giant has raised its dividend annually for 53 consecutive years, making it a Dividend King that has…
AbbVie presents long-term IBD drug data at European gastroenterology meeting
AbbVie (NYSE: ABBV) presented 20 scientific abstracts from its inflammatory bowel disease portfolio at the 2026 United European Gastroenterology Week, held October 17-20 in Barcelona, Spain, according to a company statement. Data from the…
AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years
89Stocker, towfiqu barbhuiya via Canva AbbVie (ABBV) lowered its 2026 earnings guidance in a filing on Oct. 5. Adjusted EPS is now expected at $13.76 to $13.96, down from $13.87 to $14.07, reflecting $1.25 billion of acquired IPR&D and…
Abbvie, Vertex lead $32B September biopharma M&A surge
BioWorld News Abbvie, Vertex lead $32B September biopharma M&A surge These are cookies necessary for the services to function and are always active. They are usually only set in response to actions made by the user which amount to a…
AbbVie (ABBV) Showcases Long-Term IBD Data at UEG Week 2026
On October 18, 2026, AbbVie Inc (NYSE: ABBV) announced it will present 20 new scientific abstracts highlighting its inflammatory bowel disease (IBD) portfolio at the 2026 United European Gastroenterology (UEG) Week in Barcelona. This event…
AbbVie Inc. $ABBV Stock Sold by Fulcrum Wealth Advisors LLC
Posted by Tristan Rich on Oct 18th, 2026 Get Our Latest Stock Report on AbbVie Shares of AbbVie stock opened at $285.32 on Friday. AbbVie Inc. has a 52-week low of $190.75 and a 52-week high of $291.40. The company has a 50 day moving…
AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
Early-stage results include survival comparisons in colorectal cancer and response data across several lung cancer programs. AbbVie (NYSE: ABBV) will present updated solid-tumor clinical data at the ESMO Congress in Madrid on October…
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie’s newer drugs are growing fast enough to more than replace Humira revenue. The hardest part of the transition appears to be behind it. Pfizer is making a big bet on obesity drugs. The upside is enormous, but so is the uncertainty.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
theglobeandmail.com34
-
marketscreener.com17
-
gurufocus.com14
-
fool.com12
-
tradingview.com10
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.